论文部分内容阅读
首批新药降压药Valturna获美国FDA正式批准诺华制药研发的降压药Valturna近日通过美国FDA正式批准用于临床治疗,这是第一种针对肾素系统两个关键位点的降压新药。临床上很多高血压患者单一使用阿利吉仑(Aliskiren)或血管紧张素受体抑制剂不能有效控制血压,需要多重联合用药才能达到
Valturna, the first new drug antihypertensive drug, is officially approved by the U.S. FDA Valturna, the antihypertensive drug developed by Novartis Pharmaceuticals, has been officially approved by the FDA for clinical treatment. It is the first antihypertensive drug targeting two key renin systems. Clinically, many patients with hypertension alone with Aliskiren (Aliskiren) or angiotensin receptor inhibitors can not effectively control blood pressure, the need for multiple combinations to achieve